Eli Lilly shares disappoint as sales of obesity-reducing drug.

Eli Lilly

Shares fell on Thursday as sales of the pharmaceutical company’s obesity-reducing drug fell short. However, fourth-quarter earnings exceeded estimates.

shares in

Eli Lilly

(ticker: LLY) fell 2.9% in premarket trading. Futures contract tracking

S&P 500

rose 0.5%, by comparison.


News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button